Thursday, March 19, 2009

The use of vitamin K in non-bleeding patients with excessive INRs

---was no better than placebo in this study. Patients in both groups had warfarin held.

The strategy suggested by these results, that one need only skip a dose or two of warfarin, is consistent with the Chest guidelines. These results cannot be extrapolated to the care of bleeding patients with excessive anticoagulation.

Medscape CME here.

No comments: